Publikationer

Contractile changes in the vasculature after subchronic smoking; a comparison between wild type and surfactant protein D knock out mice.

Kristian Agmund Haanes, PhD1*#, Lars Schack Kruse, PhD 1*, Helle Wulf-Johansson2, PhD, Christian Christensen Stottrup2, M.D, Grith Lykke Sorensen2, PhD, Lars Edvinsson, Dr. Med 1

 

Microfibrillar-associated protein 4 modulates airway smooth muscle cell phenotype in experimental asthma

Pilecki B1, Schlosser A1, Wulf-Johansson H1, Trian T2, Moeller JB1, Marcussen N3, Aguilar-Pimentel JA4, de Angelis MH5, Vestbo J6, Berger P7, Holmskov U1, Sorensen GL1.

 

Protective Effects of Surfactant Protein D (SP-D) Treatment in 1,3-β-glucan-modulated Allergic Inflammation

Fakih D1, Pilecki B1, Schlosser A2, Jepsen CS1, Thomsen LK1, Ormhøj M1, Watson A3, Madsen J4, Clark HW3, Barfod KK5, Hansen S1, Marcussen N6, Jounblat R7, Chamat S7, Holmskov U1, Sorensen GL8.

 

Characterization of spontaneous air space enlargement in mice lacking microfibrillar-associated protein 4

Holm AT1, Wulf-Johansson H1, Hvidsten S2, Jorgensen PT1, Schlosser A1, Pilecki B1, Ormhøj M1, Moeller JB1, Johannsen C2, Baun C2, Andersen T2, Schneider JP3, Hegermann J3, Ochs M3, Götz AA4, Schulz H5, de Angelis MH6, Vestbo J7, Holmskov U1, Sorensen GL8.

 

Ph.d.-forsvar den 30. januar 2015: Microfibrillar associated protein 4 and surfactant protein D as biomarkers of chronic obstructive pulmonary disease.

 

Surfactant protein D, Club cell protein 16, Pulmonary and activation-regulated chemokine, C-reactive protein, and Fibrinogen biomarker variation in chronic obstructive lung disease

Sofie Lock-Johansson1, Jørgen Vestbo23 and Grith Lykke Sorensen1*

 

Microfibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary disease.

Johansson SL, Roberts NB, Schlosser A, Andersen CB, Carlsen J, Wulf-Johansson H, Sækmose SG, Titlestad IL, Tornoe I, Miller B, Tal-Singer R, Holmskov U, Vestbo J, Sorensen GL.

Respir Med. 2014 Jun 20. pii: S0954-6111(14)00230-3.

 

Surfactant protein D is a candidate biomarker for subclinical tobacco smoke-induced lung damage

Johansson SL, Tan Q, Holst R, Christiansen L, Hansen NC, Hojland AT, Wulf-Johansson H, Schlosser A, Titlestad IL, Vestbo J, Holmskov U, Kyvik KO, Sorensen GL.

Am J Physiol Lung Cell Mol Physiol. 2014 May 1;306(9):L887-95. doi: 10.1152/ajplung.00340.2013. Epub 2014 Mar 7.

 

Localization of microfibrillar-associated protein 4 (MFAP4) in human tissues: clinical evaluation of serum MFAP4 and its association with various cardiovascular conditions

Wulf-Johansson H, Lock Johansson S, Schlosser A, Trommelholt Holm A, Rasmussen LM, Mickley H, Diederichsen AC, Munkholm H, Poulsen TS, Tornøe I, Nielsen V, Marcussen N, Vestbo J, Sækmose SG, Holmskov U, Sorensen GL.

PLoS One. 2013 Dec 13;8(12):e82243.

 

Enzyme-linked immunosorbent assay characterization of basal variation and heritability of systemic microfibrillar-associated protein 4

Sækmose SG, Schlosser A, Holst R, Johansson SL, Wulf-Johansson H, Tornøe I, Vestbo J, Kyvik KO, Barington T, Holmskov U, Sørensen GL.

PLoS One. 2013 Dec 4;8(12):e82383.

 

The PROTECCT-M study: a cohort study investigating associations between novel specific biomarkers, patient-related, healthcare system markers and the trajectory of COPD patients treated in primary care<//u>

Søndergaard J, Halling A.

BMC Pulm Med. 2014 May 20;14:88.